Healthcare (SH:603313) Zheng Quan Zhi Xing·2025-07-15 10:27Core Points - The company has initiated a share repurchase plan with a total expected amount between 0.85 billion to 1.70 billion RMB [1] - The repurchase period is set from May 9, 2025, to May 8, 2026 [1] - The company has already repurchased 15,999,150 shares, accounting for 2.80% of the total share capital [1] - The total amount spent on repurchased shares is approximately 137.34 million RMB [1] - The repurchase price ranged from 8.070 RMB to 9.139 RMB per share [1] Repurchase Plan Details - The board approved the share repurchase plan with a unanimous vote of 7 in favor, 0 against, and 0 abstentions [1] - The repurchase will be funded by the company's own funds and special loans [1] - The maximum repurchase price is capped at 150% of the average trading price over the previous 30 trading days prior to the board's decision [1] Progress Update - As of July 15, 2025, the company has successfully executed the share repurchase plan according to the established guidelines [2]